Literature DB >> 18389250

Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients.

J P Mostert1, Y Blaauw, M W Koch, A J Kuiper, J M Hoogduin, J De Keyser.   

Abstract

N-acetylaspartate/creatine (NAA/Cr) ratios, assessed with proton magnetic resonance spectroscopy, are increasingly used as a surrogate marker for axonal dysfunction and degeneration in multiple sclerosis (MS). The purpose of this study was to test short-time reproducibility of NAA/Cr ratios in patients with clinically stable MS. In 35 MS patients we analysed NAA/Cr ratios obtained with (1)H-MR spectroscopic imaging at the centrum semiovale either with lateral ventricles partially included (group 1; n=15) or more cranially with no ventricles included (group 2; n=20). To test short-term reproducibility of the NAA/Cr measurements, patients were scanned twice 4 weeks apart. We determined mean NAA/Cr and Cho/Cr ratios of 12 grey matter and 24 white matter voxels. Mean NAA/Cr ratios of both the white and grey matter did not change after 4 weeks. Overall 4-week reproducibility of the NAA/Cr ratio, expressed as coefficient of variation, was 4.8% for grey matter and 3.5% for white matter. Reproducibility of cranial scanning of the ventricles was slightly better than with cerebrospinal fluid included. Our study shows good short-term reproducibility of NAA/Cr ratio measurements in the centrum semiovale, which supports the reliability of this technique for longitudinal studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18389250      PMCID: PMC2469275          DOI: 10.1007/s00330-008-0925-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

Review 1.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

2.  3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Authors:  D Pelletier; S J Nelson; D Grenier; Y Lu; C Genain; D E Goodkin
Journal:  Magn Reson Imaging       Date:  2002-10       Impact factor: 2.546

3.  Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

Authors:  S Narayanan; N De Stefano; G S Francis; R Arnaoutelis; Z Caramanos; D L Collins; D Pelletier; J P Antel; D L Arnold
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

4.  Reproducibility of measurements of cerebral infarct volume on CT scans.

Authors:  H B van der Worp ; S P Claus; P R Bär; L M Ramos; A Algra; J van Gijn ; L J Kappelle
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

5.  Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.

Authors:  Jop P Mostert; Paul E Sijens; Matthijs Oudkerk; Jacques De Keyser
Journal:  Neurosci Lett       Date:  2006-04-27       Impact factor: 3.046

6.  Reproducibility of three whole-brain N-acetylaspartate decline cohorts in relapsing-remitting multiple sclerosis.

Authors:  O Gonen; T A Oberndorfer; M Inglese; J S Babb; J Herbert; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

7.  Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.

Authors:  A Parry; R Corkill; A M Blamire; J Palace; S Narayanan; D Arnold; P Styles; P M Matthews
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849

8.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

9.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; M A McLean; P Kapeller; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

10.  Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-beta therapy on absolute metabolite concentrations.

Authors:  Florian Schubert; Frank Seifert; Clemens Elster; Alfred Link; Monika Walzel; Susanne Mientus; Judith Haas; Herbert Rinneberg
Journal:  MAGMA       Date:  2002-06       Impact factor: 2.533

View more
  4 in total

1.  Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study.

Authors:  Patricia Cagnoli; Richard E Harris; Dan Frechtling; George Berkis; Richard H Gracley; Courtney C Graft; Suzan E Lowe; Thomas L Chenevert; William J McCune; Stephen Gebarski; Pia C Sundgren
Journal:  Acad Radiol       Date:  2013-10       Impact factor: 3.173

2.  Computation of brain metabolite ratios in single-voxel proton MR spectroscopy: comparison between semiautomatic and automatic software.

Authors:  L N Mazzoni; G Belli; A Ginestroni; A Pratesi; S Agnoloni; S Diciotti; M Mascalchi
Journal:  Radiol Med       Date:  2009-06-26       Impact factor: 3.469

Review 3.  Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review.

Authors:  Jeffry R Alger
Journal:  Top Magn Reson Imaging       Date:  2010-04

Review 4.  Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis.

Authors:  Oun Al-Iedani; Jeannette Lechner-Scott; Karen Ribbons; Saadallah Ramadan
Journal:  J Biomed Sci       Date:  2017-02-28       Impact factor: 8.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.